hexamethonium has been researched along with Rheumatoid Arthritis in 2 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kanashiro, A | 1 |
Talbot, J | 1 |
Peres, RS | 1 |
Pinto, LG | 1 |
Bassi, GS | 1 |
Cunha, TM | 1 |
Cunha, FQ | 1 |
PLATT, WD | 1 |
STEINBERG, IH | 1 |
2 other studies available for hexamethonium and Rheumatoid Arthritis
Article | Year |
---|---|
Neutrophil Recruitment and Articular Hyperalgesia in Antigen-Induced Arthritis are Modulated by the Cholinergic Anti-Inflammatory Pathway.
Topics: Animals; Antigens; Arthritis, Experimental; Arthritis, Rheumatoid; Atropine Derivatives; Cholinergic | 2016 |
The treatment of rheumatoid arthritis with hexamethonium chloride: a preliminary report.
Topics: Arthritis; Arthritis, Rheumatoid; Cardiovascular Agents; Hexamethonium; Muscle Relaxants, Central | 1955 |